Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14 Neoplasms 7 Endometrial Neoplasms 6 Lung Neoplasms 5 Melanoma 4 Head and Neck Neoplasms 4 Colonic Neoplasms 4 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Solitary Pulmonary Nodule 2 Multiple Pulmonary Nodules 2 Lymphedema 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Thyroid Neoplasms 1 Suspected Central Nervous System Tumors 1 Stomach Neoplasms 1 Skull Base Neoplasms 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pediatric Patients With Solid Tumors 1

Interventions

trametinib 1 talimogene laherparepvec 1 spartalizumab 1 nazartinib 1 canakinumab 1 Therapeutics 1 Telomerase 1 Radiation, Ionizing 1 Pemetrexed 1 Paclitaxel 1 Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Ductal × Indocyanine Green × Clear all

NCT01796041 2021-01-28

ICG

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Carcinoma, Lobular, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡